B., V. A REVIEW ON THE DEVELOPMENT OF FAVIPRAVIR AGAINST SARS COV 2 INFECTION. International Journal of Current Pharmaceutical Research, [S. l.], v. 14, n. 2, p. 11–14, 2022. DOI: 10.22159/ijcpr.2022v14i2.1957. Disponível em: https://mail.innovareacademics.in/journals/index.php/ijcpr/article/view/44639. Acesso em: 24 nov. 2024.